Torna al Registre Simple

 

Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study

dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorIACOBONI, GLORIA
dc.contributor.authorCABALLERO GONZÁLEZ, ANA CAROLINA
dc.contributor.authorDelgado Serrano, Javier
dc.contributor.authorBASTOS, MARIANA
dc.contributor.authorMartínez-Cibrian, Nuria
dc.contributor.authorBarba, Pere
dc.contributor.authorNavarro Garces, Victor
dc.date.accessioned2025-03-19T11:45:27Z
dc.date.available2025-03-19T11:45:27Z
dc.date.issued2025-02-04
dc.identifier.citationBastos-Oreiro M, Iacoboni G, Garcés VN, Caballero AC, Martínez N, Delgado J, et al. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 2025 Feb;9(2):e70077.
dc.identifier.issn2572-9241
dc.identifier.urihttp://hdl.handle.net/11351/12787
dc.descriptionTeràpia de cèl·lules T; Limfoma de cèl·lules B grans; Progressió de la malaltia
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesHemaSphere;9(2)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectAvaluació de resultats (Assistència sanitària)
dc.subjectCèl·lules B - Tumors - Immunoteràpia
dc.subject.meshTreatment Outcome
dc.subject.meshLymphoma, Large B-Cell, Diffuse
dc.subject.mesh/drug therapy
dc.subject.meshDisease Progression
dc.subject.meshImmunotherapy, Adoptive
dc.titleChimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/hem3.70077
dc.subject.decsresultado del tratamiento
dc.subject.decslinfoma de células B grandes difuso
dc.subject.decs/farmacoterapia
dc.subject.decsprogresión de la enfermedad
dc.subject.decsinmunoterapia adoptiva
dc.relation.publishversionhttps://doi.org/10.1002/hem3.70077
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Bastos‐Oreiro M] Hematology Department, Hospital General Universitario Gregorio Marañon, Instituto de investigación sanitaria Gregorio Marañon, Madrid, Spain. [Iacoboni G] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Department of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Garcés VN, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Caballero AC] Department d’hematologia, Hospital Sant Pau, Barcelona, Spain. [Martínez N] Servei d'Hematologia, Hospital Clínic, Barcelona, Spain. [Delgado J] Hematology Department, Virgen del Rocío, Sevilla, Spain
dc.identifier.pmid39906687
dc.identifier.wos001413884400001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document
Name:
chimeric-antigen-receptor-t-ce ...
Grandària:
393.1Kb
Format:
PDF
Description:
Chimeric antigen receptor T-cell ...
Visualitza

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple